Cargando…
Exploring the Therapeutic Potentials of iNKT Cells for Anti-HBV Treatment
CD1d-restricted invariant NKT (iNKT) cells are a group of innate-like regulatory T cells that recognize lipid antigens. Both mouse modeling experiments and human clinical studies have suggested a key role for iNKT cells in anti-HBV immunity and these potent T cells can be explored as a novel therape...
Autores principales: | Lawrenczyk, Agnieszka, Kim, Seil, Wen, Xiangshu, Xiong, Ran, Yuan, Weiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243429/ https://www.ncbi.nlm.nih.gov/pubmed/25438012 http://dx.doi.org/10.3390/pathogens3030563 |
Ejemplares similares
-
Humanizing mice for the identification of novel anticancer lipids targeting iNKT cells
por: Wen, Xiangshu, et al.
Publicado: (2013) -
α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials
por: Zhang, Yingting, et al.
Publicado: (2019) -
Tim‐3 blockade promotes iNKT cell function to inhibit HBV replication
por: Xu, Yong, et al.
Publicado: (2018) -
NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease
por: Field, Joshua J., et al.
Publicado: (2017) -
iNKT and MAIT Cell Alterations in Diabetes
por: Magalhaes, Isabelle, et al.
Publicado: (2015)